Since there is no abstract we provide the first sentence
We would like to comment on the Moller’s et al [1] very interesting report in the Annals of Surgical Oncology Journal for three reasons: (a) the findings of this study are conflicting with another study published most recently in the NEJM [2] that has been criticized for possible biases and errors [3]. (b) Which results are logically expected and most convincing to the clinic? Here it is to considered that the management of women with family history for which no data from randomized trials exist is a very controversial topic and (c) To provide an analysis of recent data available on the efficacy and safety of surgical and nonsurgical preventive interventions for women with BRCA1/2 mutations [4].
